1
|
Rai HM, Yoo J, Razaque A. Comparative analysis of machine learning and deep learning models for improved cancer detection: A comprehensive review of recent advancements in diagnostic techniques. EXPERT SYSTEMS WITH APPLICATIONS 2024; 255:124838. [DOI: 10.1016/j.eswa.2024.124838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/11/2024]
|
2
|
Islam MM, Rifat HR, Shahid MSB, Akhter A, Uddin MA. Utilizing Deep Feature Fusion for Automatic Leukemia Classification: An Internet of Medical Things-Enabled Deep Learning Framework. SENSORS (BASEL, SWITZERLAND) 2024; 24:4420. [PMID: 39001200 PMCID: PMC11244606 DOI: 10.3390/s24134420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/24/2024] [Revised: 06/30/2024] [Accepted: 07/05/2024] [Indexed: 07/16/2024]
Abstract
Acute lymphoblastic leukemia, commonly referred to as ALL, is a type of cancer that can affect both the blood and the bone marrow. The process of diagnosis is a difficult one since it often calls for specialist testing, such as blood tests, bone marrow aspiration, and biopsy, all of which are highly time-consuming and expensive. It is essential to obtain an early diagnosis of ALL in order to start therapy in a timely and suitable manner. In recent medical diagnostics, substantial progress has been achieved through the integration of artificial intelligence (AI) and Internet of Things (IoT) devices. Our proposal introduces a new AI-based Internet of Medical Things (IoMT) framework designed to automatically identify leukemia from peripheral blood smear (PBS) images. In this study, we present a novel deep learning-based fusion model to detect ALL types of leukemia. The system seamlessly delivers the diagnostic reports to the centralized database, inclusive of patient-specific devices. After collecting blood samples from the hospital, the PBS images are transmitted to the cloud server through a WiFi-enabled microscopic device. In the cloud server, a new fusion model that is capable of classifying ALL from PBS images is configured. The fusion model is trained using a dataset including 6512 original and segmented images from 89 individuals. Two input channels are used for the purpose of feature extraction in the fusion model. These channels include both the original and the segmented images. VGG16 is responsible for extracting features from the original images, whereas DenseNet-121 is responsible for extracting features from the segmented images. The two output features are merged together, and dense layers are used for the categorization of leukemia. The fusion model that has been suggested obtains an accuracy of 99.89%, a precision of 99.80%, and a recall of 99.72%, which places it in an excellent position for the categorization of leukemia. The proposed model outperformed several state-of-the-art Convolutional Neural Network (CNN) models in terms of performance. Consequently, this proposed model has the potential to save lives and effort. For a more comprehensive simulation of the entire methodology, a web application (Beta Version) has been developed in this study. This application is designed to determine the presence or absence of leukemia in individuals. The findings of this study hold significant potential for application in biomedical research, particularly in enhancing the accuracy of computer-aided leukemia detection.
Collapse
Affiliation(s)
- Md Manowarul Islam
- Department of Computer Science and Engineering, Jagannath University, Dhaka 1100, Bangladesh
| | - Habibur Rahman Rifat
- Department of Computer Science and Engineering, Jagannath University, Dhaka 1100, Bangladesh
| | - Md Shamim Bin Shahid
- Department of Computer Science and Engineering, Jagannath University, Dhaka 1100, Bangladesh
| | - Arnisha Akhter
- Department of Computer Science and Engineering, Jagannath University, Dhaka 1100, Bangladesh
| | - Md Ashraf Uddin
- School of Info Technology, Deakin University, Burwood, VIC 3125, Australia
| |
Collapse
|
3
|
Rubinos Rodriguez J, Fernandez S, Swartz N, Alonge A, Bhullar F, Betros T, Girdler M, Patel N, Adas S, Cervone A, Jacobs RJ. A Chronological Overview of Using Deep Learning for Leukemia Detection: A Scoping Review. Cureus 2024; 16:e61379. [PMID: 38947677 PMCID: PMC11214573 DOI: 10.7759/cureus.61379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Accepted: 05/30/2024] [Indexed: 07/02/2024] Open
Abstract
Leukemia is a rare but fatal cancer of the blood. This cancer arises from abnormal bone marrow cells and requires prompt diagnosis for effective treatment and positive patient prognosis. Traditional diagnostic methods (e.g., microscopy, flow cytometry, and biopsy) pose challenges in both accuracy and time, demanding an inquisition on the development and use of deep learning (DL) models, such as convolutional neural networks (CNN), which could allow for a faster and more exact diagnosis. Using specific, objective criteria, DL might hold promise as a tool for physicians to diagnose leukemia. The purpose of this review was to report the relevant available published literature on using DL to diagnose leukemia. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, articles published between 2010 and 2023 were searched using Embase, Ovid MEDLINE, and Web of Science, searching the terms "leukemia" AND "deep learning" or "artificial neural network" OR "neural network" AND "diagnosis" OR "detection." After screening retrieved articles using pre-determined eligibility criteria, 20 articles were included in the final review and reported chronologically due to the nascent nature of the phenomenon. The initial studies laid the groundwork for subsequent innovations, illustrating the transition from specialized methods to more generalized approaches capitalizing on DL technologies for leukemia detection. This summary of recent DL models revealed a paradigm shift toward integrated architectures, resulting in notable enhancements in accuracy and efficiency. The continuous refinement of models and techniques, coupled with an emphasis on simplicity and efficiency, positions DL as a promising tool for leukemia detection. With the help of these neural networks, leukemia detection could be hastened, allowing for an improved long-term outlook and prognosis. Further research is warranted using real-life scenarios to confirm the suggested transformative effects DL models could have on leukemia diagnosis.
Collapse
Affiliation(s)
- Jorge Rubinos Rodriguez
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Santiago Fernandez
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Nicholas Swartz
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Austin Alonge
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Fahad Bhullar
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Trevor Betros
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Michael Girdler
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Neil Patel
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Sayf Adas
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Adam Cervone
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| | - Robin J Jacobs
- Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA
| |
Collapse
|
4
|
Perumalraja R, Felcia Logan's Deshna B, Swetha N. Statistical performance review on diagnosis of leukemia, glaucoma and diabetes mellitus using AI. Stat Med 2024; 43:1227-1237. [PMID: 38247116 DOI: 10.1002/sim.10004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Revised: 12/28/2023] [Accepted: 12/29/2023] [Indexed: 01/23/2024]
Abstract
The growth of artificial intelligence (AI) in the healthcare industry tremendously increases the patient outcomes by reshaping the way we diagnose, treat and monitor patients. AI-based innovation in healthcare include exploration of drugs, personalized medicine, clinical diagnosis investigations, robotic-assisted surgery, verified prescriptions, pregnancy care for women, radiology, and reviewed patient information analytics. However, prediction of AI-based solutions are depends mainly on the implementation of statistical algorithms and input data set. In this article, statistical performance review on various algorithms, Accuracy, Precision, Recall and F1-Score used to predict the diagnosis of leukemia, glaucoma, and diabetes mellitus is presented. Review on statistical algorithms' performance, used for individual disease diagnosis gives a complete picture of various research efforts during the last two decades. At the end of statistical review on each disease diagnosis, we have discussed our inferences that will give future directions for the new researchers on selection of AI statistical algorithm as well as the input data set.
Collapse
Affiliation(s)
- Rengaraju Perumalraja
- Department of Information Technology, Velammal College of Engineering and Technology, Madurai, India
| | - B Felcia Logan's Deshna
- Department of Information Technology, Velammal College of Engineering and Technology, Madurai, India
| | - N Swetha
- Department of Information Technology, Velammal College of Engineering and Technology, Madurai, India
| |
Collapse
|
5
|
Tarquino J, Arabyarmohammadi S, Tejada RE, Madabhushi A, Romero E. Intra-nucleus mosaic pattern (InMop) and whole-cell Haralick combined-descriptor for identifying and characterizing acute leukemia blasts on single cell peripheral blood images. Cytometry A 2023; 103:857-867. [PMID: 37565838 PMCID: PMC10841385 DOI: 10.1002/cyto.a.24785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2022] [Revised: 07/14/2023] [Accepted: 08/08/2023] [Indexed: 08/12/2023]
Abstract
Acute leukemia is usually diagnosed when a test of peripheral blood shows at least 20% of abnormal immature cells (blasts), a figure even lower in case of recurrent cytogenetic abnormalities. Blast identification is crucial for white blood cell (WBC) counting, which depends on both identifying the cell type and characterizing the cellular morphology, processes susceptible of inter- and intraobserver variability. The present work introduces an image combined-descriptor to detect blasts and determine their probable lineage. This strategy uses an intra-nucleus mosaic pattern (InMop) descriptor that captures subtle nuclei differences within WBCs, and Haralick's statistics which quantify the local structure of both nucleus and cytoplasm. The InMop captures WBC inner-nucleus structure by applying a multiscale Shearlet decomposition over a repetitive pattern (mosaic) of automatically-segmented nuclei. As a complement, Haralick's statistics characterize the local structure of the whole cell from an intensity co-occurrence matrix representation. Both InMoP and Haralick-based descriptors are calculated using the b-channel from Lab color-space. The combined-descriptor is assessed by differentiating blasts from nonleukemic cells with support vector machine (SVM) classifiers and different transformation kernels, in two public and independent databases. The first database-D1 (n = 260) is composed of healthy and acute lymphoid leukemia (ALL) single cell images, and second database-D2 contains acute myeloid leukemia (AML) blasts (n = 3294) and nonblast (n = 15,071) cell images. In a first experiment, blasts versus nonblast differentiation is performed by training with a subset of D2 (n = 6588) and testing in D1 (n = 260), obtaining a training AUC of 0.991 ± 0.002 and AUC = 0.782 for the independent validation. A second experiment automatically differentiates AML blasts (260 images from D2) from ALL blasts (260 images from D1), with an AUC of 0.93. In a third experiment, state-of-the-art strategies, VGG16 and RESNEXT convolutional neural networks (CNN), separate blast from nonblast cells in both databases. The VGG16 showed an AUC of 0.673 and the RESNEXT of 0.75. Reported metrics for all the experiments are area under the ROC curve (AUC), accuracy and F1-score.
Collapse
Affiliation(s)
- Jonathan Tarquino
- Computer Imaging and Medical Application Laboratory, Universidad Nacional de Colombia, Bogotá, Colombia
| | - Sara Arabyarmohammadi
- Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, GA, USA
| | - Rafael Enrique Tejada
- Department of internal medicine, Hemato-oncology unit, Medicine Faculty, Universidad Nacional de Colombia, Bogotá, Colombia
| | - Anant Madabhushi
- Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, GA, USA
- Atlanta Veterans Medical Center, Atlanta, GA, USA
| | - Eduardo Romero
- Computer Imaging and Medical Application Laboratory, Universidad Nacional de Colombia, Bogotá, Colombia
| |
Collapse
|
6
|
Yadav DP, Kumar D, Jalal AS, Kumar A, Singh KU, Shah MA. Morphological diagnosis of hematologic malignancy using feature fusion-based deep convolutional neural network. Sci Rep 2023; 13:16988. [PMID: 37813973 PMCID: PMC10562409 DOI: 10.1038/s41598-023-44210-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Accepted: 10/05/2023] [Indexed: 10/11/2023] Open
Abstract
Leukemia is a cancer of white blood cells characterized by immature lymphocytes. Due to blood cancer, many people die every year. Hence, the early detection of these blast cells is necessary for avoiding blood cancer. A novel deep convolutional neural network (CNN) 3SNet that has depth-wise convolution blocks to reduce the computation costs has been developed to aid the diagnosis of leukemia cells. The proposed method includes three inputs to the deep CNN model. These inputs are grayscale and their corresponding histogram of gradient (HOG) and local binary pattern (LBP) images. The HOG image finds the local shape, and the LBP image describes the leukaemia cell's texture pattern. The suggested model was trained and tested with images from the AML-Cytomorphology_LMU dataset. The mean average precision (MAP) for the cell with less than 100 images in the dataset was 84%, whereas for cells with more than 100 images in the dataset was 93.83%. In addition, the ROC curve area for these cells is more than 98%. This confirmed proposed model could be an adjunct tool to provide a second opinion to a doctor.
Collapse
Affiliation(s)
- D P Yadav
- Department of Computer Engineering and Applications, G.L.A. University, Mathura, 281406, India
| | - Deepak Kumar
- Department of Computer Science, NIT Meghalaya, Shillong, 793003, India
| | - Anand Singh Jalal
- Department of Computer Engineering and Applications, G.L.A. University, Mathura, 281406, India
| | - Ankit Kumar
- Department of Computer Engineering and Applications, G.L.A. University, Mathura, 281406, India
| | - Kamred Udham Singh
- School of Computing, Graphic Era Hill University, Dehradun, 248002, India
| | - Mohd Asif Shah
- Kebri Dehar University, Kebri Dehar, Ethiopia.
- Woxsen University, Kamkole, Sadasivpet, Hyderabad, Telangana, 502345, India.
- Division of Research and Development, Lovely Professional University, Phagwara, Punjab, 144001, India.
- Research Fellow, INTI International University, Persiaran Perdana BBN Putra, Nilai, Negeri Sembilan, 71800, Malaysia.
| |
Collapse
|
7
|
Kaur M, AlZubi AA, Jain A, Singh D, Yadav V, Alkhayyat A. DSCNet: Deep Skip Connections-Based Dense Network for ALL Diagnosis Using Peripheral Blood Smear Images. Diagnostics (Basel) 2023; 13:2752. [PMID: 37685290 PMCID: PMC10486457 DOI: 10.3390/diagnostics13172752] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 08/16/2023] [Accepted: 08/18/2023] [Indexed: 09/10/2023] Open
Abstract
Acute lymphoblastic leukemia (ALL) is a life-threatening hematological malignancy that requires early and accurate diagnosis for effective treatment. However, the manual diagnosis of ALL is time-consuming and can delay critical treatment decisions. To address this challenge, researchers have turned to advanced technologies such as deep learning (DL) models. These models leverage the power of artificial intelligence to analyze complex patterns and features in medical images and data, enabling faster and more accurate diagnosis of ALL. However, the existing DL-based ALL diagnosis suffers from various challenges, such as computational complexity, sensitivity to hyperparameters, and difficulties with noisy or low-quality input images. To address these issues, in this paper, we propose a novel Deep Skip Connections-Based Dense Network (DSCNet) tailored for ALL diagnosis using peripheral blood smear images. The DSCNet architecture integrates skip connections, custom image filtering, Kullback-Leibler (KL) divergence loss, and dropout regularization to enhance its performance and generalization abilities. DSCNet leverages skip connections to address the vanishing gradient problem and capture long-range dependencies, while custom image filtering enhances relevant features in the input data. KL divergence loss serves as the optimization objective, enabling accurate predictions. Dropout regularization is employed to prevent overfitting during training, promoting robust feature representations. The experiments conducted on an augmented dataset for ALL highlight the effectiveness of DSCNet. The proposed DSCNet outperforms competing methods, showcasing significant enhancements in accuracy, sensitivity, specificity, F-score, and area under the curve (AUC), achieving increases of 1.25%, 1.32%, 1.12%, 1.24%, and 1.23%, respectively. The proposed approach demonstrates the potential of DSCNet as an effective tool for early and accurate ALL diagnosis, with potential applications in clinical settings to improve patient outcomes and advance leukemia detection research.
Collapse
Affiliation(s)
- Manjit Kaur
- School of Computer Science and Artificial Intelligence, SR University, Warangal 506371, India;
| | - Ahmad Ali AlZubi
- Department of Computer Science, Community College, King Saud University, Riyadh 11421, Saudi Arabia;
| | - Arpit Jain
- Department of Computer Science and Engineering, Koneru Lakshmaiah Education Foundation, Vijayawada 522302, India;
| | - Dilbag Singh
- Center of Biomedical Imaging, Department of Radiology, New York University Grossman School of Medicine, New York, NY 10016, USA
- Research and Development Cell, Lovely Professional University, Phagwara 144411, India
| | - Vaishali Yadav
- School of Computer and Communication Engineering, Manipal University Jaipur, Jaipur 303007, India
| | - Ahmed Alkhayyat
- College of Technical Engineering, The Islamic University, Najaf 7003, Iraq;
| |
Collapse
|
8
|
Atteia G, Alnashwan R, Hassan M. Hybrid Feature-Learning-Based PSO-PCA Feature Engineering Approach for Blood Cancer Classification. Diagnostics (Basel) 2023; 13:2672. [PMID: 37627931 PMCID: PMC10453878 DOI: 10.3390/diagnostics13162672] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 08/09/2023] [Accepted: 08/10/2023] [Indexed: 08/27/2023] Open
Abstract
Acute lymphoblastic leukemia (ALL) is a lethal blood cancer that is characterized by an abnormal increased number of immature lymphocytes in the blood or bone marrow. For effective treatment of ALL, early assessment of the disease is essential. Manual examination of stained blood smear images is current practice for initially screening ALL. This practice is time-consuming and error-prone. In order to effectively diagnose ALL, numerous deep-learning-based computer vision systems have been developed for detecting ALL in blood peripheral images (BPIs). Such systems extract a huge number of image features and use them to perform the classification task. The extracted features may contain irrelevant or redundant features that could reduce classification accuracy and increase the running time of the classifier. Feature selection is considered an effective tool to mitigate the curse of the dimensionality problem and alleviate its corresponding shortcomings. One of the most effective dimensionality-reduction tools is principal component analysis (PCA), which maps input features into an orthogonal space and extracts the features that convey the highest variability from the data. Other feature selection approaches utilize evolutionary computation (EC) to search the feature space and localize optimal features. To profit from both feature selection approaches in improving the classification performance of ALL, in this study, a new hybrid deep-learning-based feature engineering approach is proposed. The introduced approach integrates the powerful capability of PCA and particle swarm optimization (PSO) approaches in selecting informative features from BPI mages with the power of pre-trained CNNs of feature extraction. Image features are first extracted through the feature-transfer capability of the GoogleNet convolutional neural network (CNN). PCA is utilized to generate a feature set of the principal components that covers 95% of the variability in the data. In parallel, bio-inspired particle swarm optimization is used to search for the optimal image features. The PCA and PSO-derived feature sets are then integrated to develop a hybrid set of features that are then used to train a Bayesian-based optimized support vector machine (SVM) and subspace discriminant ensemble-learning (SDEL) classifiers. The obtained results show improved classification performance for the ML classifiers trained by the proposed hybrid feature set over the original PCA, PSO, and all extracted feature sets for ALL multi-class classification. The Bayesian-optimized SVM trained with the proposed hybrid PCA-PSO feature set achieves the highest classification accuracy of 97.4%. The classification performance of the proposed feature engineering approach competes with the state of the art.
Collapse
Affiliation(s)
- Ghada Atteia
- Department of Information Technology, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia;
| | - Rana Alnashwan
- Department of Information Technology, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia;
| | - Malak Hassan
- College of Medicine, Alfaisal University, P.O. Box 50927, Riyadh 11533, Saudi Arabia;
| |
Collapse
|
9
|
Ahmed IA, Senan EM, Shatnawi HSA, Alkhraisha ZM, Al-Azzam MMA. Hybrid Techniques for the Diagnosis of Acute Lymphoblastic Leukemia Based on Fusion of CNN Features. Diagnostics (Basel) 2023; 13:diagnostics13061026. [PMID: 36980334 PMCID: PMC10047564 DOI: 10.3390/diagnostics13061026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 03/03/2023] [Accepted: 03/06/2023] [Indexed: 03/30/2023] Open
Abstract
Acute lymphoblastic leukemia (ALL) is one of the deadliest forms of leukemia due to the bone marrow producing many white blood cells (WBC). ALL is one of the most common types of cancer in children and adults. Doctors determine the treatment of leukemia according to its stages and its spread in the body. Doctors rely on analyzing blood samples under a microscope. Pathologists face challenges, such as the similarity between infected and normal WBC in the early stages. Manual diagnosis is prone to errors, differences of opinion, and the lack of experienced pathologists compared to the number of patients. Thus, computer-assisted systems play an essential role in assisting pathologists in the early detection of ALL. In this study, systems with high efficiency and high accuracy were developed to analyze the images of C-NMC 2019 and ALL-IDB2 datasets. In all proposed systems, blood micrographs were improved and then fed to the active contour method to extract WBC-only regions for further analysis by three CNN models (DenseNet121, ResNet50, and MobileNet). The first strategy for analyzing ALL images of the two datasets is the hybrid technique of CNN-RF and CNN-XGBoost. DenseNet121, ResNet50, and MobileNet models extract deep feature maps. CNN models produce high features with redundant and non-significant features. So, CNN deep feature maps were fed to the Principal Component Analysis (PCA) method to select highly representative features and sent to RF and XGBoost classifiers for classification due to the high similarity between infected and normal WBC in early stages. Thus, the strategy for analyzing ALL images using serially fused features of CNN models. The deep feature maps of DenseNet121-ResNet50, ResNet50-MobileNet, DenseNet121-MobileNet, and DenseNet121-ResNet50-MobileNet were merged and then classified by RF classifiers and XGBoost. The RF classifier with fused features for DenseNet121-ResNet50-MobileNet reached an AUC of 99.1%, accuracy of 98.8%, sensitivity of 98.45%, precision of 98.7%, and specificity of 98.85% for the C-NMC 2019 dataset. With the ALL-IDB2 dataset, hybrid systems achieved 100% results for AUC, accuracy, sensitivity, precision, and specificity.
Collapse
Affiliation(s)
| | - Ebrahim Mohammed Senan
- Department of Artificial Intelligence, Faculty of Computer Science and Information Technology, Alrazi University, Sana'a, Yemen
| | | | | | | |
Collapse
|
10
|
Biomedical Diagnosis of Leukemia Using a Deep Learner Classifier. COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE 2022; 2022:1568375. [PMID: 36072723 PMCID: PMC9444372 DOI: 10.1155/2022/1568375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/25/2022] [Accepted: 07/28/2022] [Indexed: 11/23/2022]
Abstract
Leukemia cancer is the most common type of cancer that occurs in childhood. The most common types are acute lymphocytic leukemia (ALL) and acute myelogenous leukemia (AML) which affect children and adults, respectively. Several health issues occur due to these cancers. Leukemia affects the bone marrow or the lymph nodes. Leukemia produces abnormal white blood cells via the bone marrow system. The affected white blood cells are unable to perform their tasks properly. Detecting leukemia usually requires taking a blood smear from a patient and working with expert hematologists who analyze the smear with a microscope. In this paper, a method to detect ALL and AML using a deep learner classifier is developed and proposed. The method detects both types, determines their severity, and creates a message that recommends next steps to patients. This approach works based on image segmentation and a convolutional neural network (CNN) tool called AlexNet. The obtained results from the proposed approach and using MATLAB reached more than 98% accuracy. The margin exists because several operations are needed to fully detect the blood cancer. A dataset of leukemia from the Kaggle site is used to test the developed method and illustrate its effectiveness. This dataset is C-NMC_Leukemia, and it consists of nearly 10 GB worth of 15,000 images. A confusion matrix of testing images is provided to prove the correctness of the presented approach. Furthermore, a comparative analysis between the proposed algorithm and some works from the literature is presented. This analysis compares the method used to extract features, the classifier that is utilized, the accuracy, the precision, and the recall. The obtained results indicate that the proposed method outperforms other works and produces better results.
Collapse
|
11
|
El Alaoui Y, Elomri A, Qaraqe M, Padmanabhan R, Yasin Taha R, El Omri H, El Omri A, Aboumarzouk O. A Review of Artificial Intelligence Applications in Hematology Management: Current Practices and Future Prospects. J Med Internet Res 2022; 24:e36490. [PMID: 35819826 PMCID: PMC9328784 DOI: 10.2196/36490] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2022] [Revised: 05/14/2022] [Accepted: 05/29/2022] [Indexed: 12/23/2022] Open
Abstract
Background Machine learning (ML) and deep learning (DL) methods have recently garnered a great deal of attention in the field of cancer research by making a noticeable contribution to the growth of predictive medicine and modern oncological practices. Considerable focus has been particularly directed toward hematologic malignancies because of the complexity in detecting early symptoms. Many patients with blood cancer do not get properly diagnosed until their cancer has reached an advanced stage with limited treatment prospects. Hence, the state-of-the-art revolves around the latest artificial intelligence (AI) applications in hematology management. Objective This comprehensive review provides an in-depth analysis of the current AI practices in the field of hematology. Our objective is to explore the ML and DL applications in blood cancer research, with a special focus on the type of hematologic malignancies and the patient’s cancer stage to determine future research directions in blood cancer. Methods We searched a set of recognized databases (Scopus, Springer, and Web of Science) using a selected number of keywords. We included studies written in English and published between 2015 and 2021. For each study, we identified the ML and DL techniques used and highlighted the performance of each model. Results Using the aforementioned inclusion criteria, the search resulted in 567 papers, of which 144 were selected for review. Conclusions The current literature suggests that the application of AI in the field of hematology has generated impressive results in the screening, diagnosis, and treatment stages. Nevertheless, optimizing the patient’s pathway to treatment requires a prior prediction of the malignancy based on the patient’s symptoms or blood records, which is an area that has still not been properly investigated.
Collapse
Affiliation(s)
- Yousra El Alaoui
- College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar
| | - Adel Elomri
- College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar
| | - Marwa Qaraqe
- College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar
| | - Regina Padmanabhan
- College of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar
| | - Ruba Yasin Taha
- National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
| | - Halima El Omri
- National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
| | - Abdelfatteh El Omri
- Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar
| | - Omar Aboumarzouk
- Surgical Research Section, Department of Surgery, Hamad Medical Corporation, Doha, Qatar.,College of Medicine, Qatar University, Doha, Qatar.,College of Medicine, University of Glasgow, Glasgow, United Kingdom
| |
Collapse
|
12
|
Liu K, Hu J. Classification of acute myeloid leukemia M1 and M2 subtypes using machine learning. Comput Biol Med 2022; 147:105741. [PMID: 35738057 DOI: 10.1016/j.compbiomed.2022.105741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 05/24/2022] [Accepted: 06/11/2022] [Indexed: 11/25/2022]
Abstract
BACKGROUND Classification of acute myeloid leukemia (AML) relies on manual analysis of bone marrow or peripheral blood smear images. We aimed to construct a machine learning model for automatic classification of AML-M1 and M2 subtypes in bone marrow smear images. METHODS Bone marrow smear images of AML patients were extracted from the Cancer Imaging Archive (TCIA) open database. Classification criteria of AML subtypes were based on the French-American-British (FAB) classification system. Random forest method and broad learning system (BLS) were used to develop the classification model. Morphological features, radiomics features, and clinical features were extracted. The performance of the classification model was evaluated by calculating accuracy, precision, recall, F1-score, and area under the curve (AUC). A total of 50 bone marrow smear images (AML-M1, 31 cases; AML-M2, 19 cases) with 500 slices were included in this study. RESULTS A total of 43 morphological features, 276 radiomics features, and 1 clinical feature were extracted. Finally, 9 variables including 2 morphological features, 6 radiomics features, and 1 clinical feature were selected into the classification model. The best classification performance was observed in the random forest model with 9 variables, with the average accuracy, AUC, F1-score, recall, and precision of the model being 0.998 ± 0.003, 0.998 ± 0.004, 0.998 ± 0.004, 0.996 ± 0.009, and 1 ± 0, respectively. CONCLUSION The random forest model performed well for the classification of AML-M1 and M2, which may provide a tool for clinicians to classify AML-M1 and M2.
Collapse
Affiliation(s)
- Ke Liu
- Department of Hematology, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China.
| | - Jie Hu
- Department of Medical Record Management, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China
| |
Collapse
|
13
|
Abstract
Melanoma skin cancer is one of the most dangerous types of skin cancer, which, if not diagnosed early, may lead to death. Therefore, an accurate diagnosis is needed to detect melanoma. Traditionally, a dermatologist utilizes a microscope to inspect and then provide a report on a biopsy for diagnosis; however, this diagnosis process is not easy and requires experience. Hence, there is a need to facilitate the diagnosis process while still yielding an accurate diagnosis. For this purpose, artificial intelligence techniques can assist the dermatologist in carrying out diagnosis. In this study, we considered the detection of melanoma through deep learning based on cutaneous image processing. For this purpose, we tested several convolutional neural network (CNN) architectures, including DenseNet201, MobileNetV2, ResNet50V2, ResNet152V2, Xception, VGG16, VGG19, and GoogleNet, and evaluated the associated deep learning models on graphical processing units (GPUs). A dataset consisting of 7146 images was processed using these models, and we compared the obtained results. The experimental results showed that GoogleNet can obtain the highest performance accuracy on both the training and test sets (74.91% and 76.08%, respectively).
Collapse
|